<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350333</id>
  <title nil="true"/>
  <common-name>2-[3-(4-ethoxyphenyl)-4-oxoquinazolin-2-yl]sulfanyl-n-(2-phenylphenyl)acetamide</common-name>
  <description>2-[3-(4-ethoxyphenyl)-4-oxoquinazolin-2-yl]sulfanyl-n-(2-phenylphenyl)acetamide is a chemical compound with the formula C30H25N3O3S. With an average molecular weight of 507.60 g/mol, 2-[3-(4-ethoxyphenyl)-4-oxoquinazolin-2-yl]sulfanyl-n-(2-phenylphenyl)acetamide is a heavy molecule.</description>
  <cas>618432-29-4</cas>
  <pubchem-id>1892059</pubchem-id>
  <chemical-formula>C30H25N3O3S</chemical-formula>
  <weight>507.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:20:27Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:20:27Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCOC1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3N=C2SCC(=O)NC4=CC=CC=C4C5=CC=CC=C5</moldb-smiles>
  <moldb-formula>C30H25N3O3S</moldb-formula>
  <moldb-inchi>InChI=1S/C30H25N3O3S/c1-2-36-23-18-16-22(17-19-23)33-29(35)25-13-7-9-15-27(25)32-30(33)37-20-28(34)31-26-14-8-6-12-24(26)21-10-4-3-5-11-21/h3-19H,2,20H2,1H3,(H,31,34)</moldb-inchi>
  <moldb-inchikey>DHDQHNFSORHRDD-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">507.1616628</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346226</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[3-(4-ethoxyphenyl)-4-oxoquinazolin-2-yl]sulfanyl-n-(2-phenylphenyl)acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Biphenyls and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300640</sync-id>
  <structure-inchikey>DHDQHNFSORHRDD-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000200400800002100800000000000000000000000002004400000002000042000020200004008000002084000000000000000000000000000080200000000000000000000000000000000020000000200100000200408010000000000000010000000000000000000000000000000100000000000080000000000000000040000000804000000000000080800000000100000080020000000000000000000000000000040000080000000000000000090000000000002000000008000000040000002000000000000000000000008000000000000200000000000000008040000001000040000000000400000008010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:18Z</structure-indexed-at>
</compound>
